Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacza 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Craza Lifesciences Pvt Ltd

Salt Composition

Tacrolimus (0.03% w/w)

Overview Tacza 0.03% Ointment

Eczema (atopic dermatitis) is treated with Tacza 0.03% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Tacza 0.03% Ointment topically 2-4 times daily to affected areas, or as directed by your physician. Gently and evenly rub it in. Avoid over-application and do not bandage or cover treated skin. Consult your doctor if no improvement is seen after two weeks or if your condition worsens. Common side effects may include redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Use during pregnancy or breastfeeding is generally not advised unless deemed essential by your doctor.

Uses of Tacza 0.03% Ointment

Managing atopic eczema

Major Benefits of Tacza 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application details prior to use. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

Common Side effects of Tacza 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacza 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

How Tacza 0.03% Ointment works:

Immunosuppressant Tacza 0.03% Ointment reduces skin inflammation—the redness and swelling—by inhibiting the action of specific immune cells. This alleviates itching and enhances the appearance of atopic dermatitis rashes.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacza 0.03% Ointment during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Topical Tacza 0.03% ointment is likely compatible with breastfeeding. Available human data indicates minimal risk to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacza 0.03% Ointment :

Should you forget a dose of Tacza 0.03% Ointment, apply it promptly. If, however, your next scheduled dose is imminent, omit the missed application and resume your usual dosing regimen.

Facts to Know About Tacza 0.03% Ointment

LabelValue
Chemical Type Macrolide Antibiotics
Developing Good Habits No.
Treatment Category Cancer Medications
Action Class Calcineurin inhibitor immunosuppressants

FAQs on Tacza 0.03% Ointment

Tacza 0.03% Ointment is an immune-modulating medication that primarily reduces immune system activity. It's indicated for adults with moderate to severe atopic dermatitis (eczema) who haven't responded to, or experience side effects from, steroid treatments. Atopic dermatitis involves an overactive skin immune response causing inflammation, itch, redness, and dryness. Tacza 0.03% Ointment works by correcting this abnormal immune response, thereby relieving inflammation and itching.
Applying Tacza 0.03% Ointment may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These side effects typically resolve within a week. Use may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacza 0.03% Ointment offers safe and effective short-term atopic dermatitis treatment, demonstrating superior safety compared to other immunosuppressants. Its minimal systemic absorption after topical application results in fewer side effects than oral treatments.
Tacza 0.03% Ointment is not a controlled substance and does not have abuse potential. Controlled substances require authorization from both a doctor and relevant authorities due to their potential for misuse.
Prolonged use of Tacza 0.03% Ointment may increase the risk of lymphoma (a type of lymph node tumor). Studies indicate a link between Tacza 0.03% Ointment, or similar medications, and the development of skin cancer or lymphoma in a small number of patients. If you use Tacza 0.03% Ointment for over six weeks, or if your eczema symptoms worsen or fail to improve, consult your physician.
Tacza 0.03% Ointment is a non-steroidal medication that regulates the immune system. Primarily used for eczema, particularly atopic dermatitis, it avoids the skin thinning and other adverse effects associated with steroids.
Tacza 0.03% Ointment
107
MRP 130
17% off